• Case control, proof-of-concept study
• Adult patients with hypoxemic respiratory failure
• N = 5 ASA + clopidogrel + tirofiban + fondaparinux + standard care
•  N = 5 matched controls given low molecular weight heparin
• Secondary outcome included major and minor cardiac adverse events